TY  - GEN
AU  - Trappe,Ralf
AU  - Oertel,Stephan
AU  - Leblond,Veronique
AU  - Mollee,Peter
AU  - Sender,Monica
AU  - Reinke,Petra
AU  - Neuhaus,Ruth
AU  - Lehmkuhl,Hans
AU  - Horst,Heinz August
AU  - Salles,Gilles
AU  - Morschhauser,Franck
AU  - Jaccard,Arnaud
AU  - Lamy,Thierry
AU  - Leithäuser,Malte
AU  - Zimmermann,Heiner
AU  - Anagnostopoulos,Ioannis
AU  - Raphael,Martine
AU  - Riess,Hanno
AU  - Choquet,Sylvain
TI  - Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
SN  - 1474-5488
PY  - 2012///0320
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antigens, CD20
KW  - immunology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Epstein-Barr Virus Infections
KW  - diagnosis
KW  - Female
KW  - France
KW  - Germany
KW  - Herpesvirus 4, Human
KW  - pathogenicity
KW  - Humans
KW  - Lymphoproliferative Disorders
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Organ Transplantation
KW  - adverse effects
KW  - Prednisolone
KW  - Prospective Studies
KW  - Rituximab
KW  - Vincristine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(11)70300-X
ER  -